Global /China /Healthcare /Drug Manufacturers - General /000766
chevron_leftBack
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd logo

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

000766
SHE: 000766 Delayed
24.67CNY 3.1%
3.65 USD
As of 19 June 2026, Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd has a market cap of $3.42B USD, ranking #4968 globally and #1043 in China. It ranks #385 in the Healthcare sector, and #151 in the Drug Manufacturers - General industry.
Global Rank
4968
Country Rank
1043
Sector Rank
385
Industry Rank
151
Key Stats
Market Cap
$3.42BUSD
23.12B CNY
Enterprise Value
$3.65BUSD
24.64B CNY
Revenue (TTM)
$173.24MUSD
1.17B CNY
EBITDA (TTM)
$25.26MUSD
170.72M CNY
Net Income (TTM)
$4.71MUSD
31.83M CNY
EBITDA Margin
15%
Profit Margin
2.7%
PE Ratio
726.2
PS Ratio
19.7
PB Ratio
10.0
EV/EBITDA
143.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Yufu Zhang open_in_new
Employees
1,480
Founded
1990
Website
thjm.cn open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
3.1% 7.4% 25% -7.3% -3.2% 36%

News

Loading...

Markets

Exchange Ticker Price
Shenzhen Stock Exchange
MIC: XSHE
PRIMARY
000766
通化金马药业集团股份有限公司 Class A
ISIN: CNE000000735
Shares Out.:
966.495M1 Shares Float: 495.761M2
TV:
SA:
YF:
GF:
BA:
MS:
24.67 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. The company provides anti-tumor drugs, gynecological medications, medication for rheumatic bone pain, urological medications, heat-clearing and detoxifying drugs, cardiovascular and cerebrovascular drugs, digestive medications, tonifying and restorative medicines, respiratory medication, diabetes medication, ENT medication, and pediatric medications. It also offers Xiaojin pills, Tian Ranshexiang Xiaojin pills, Xiaokechuan capsules, Jiuwei Qianghuo granules, Xiongdan powder, Bear Bile powder, and Wenweishu tablets to treat glandular hyperplasia, inflammatory diseases, bone trauma and soft tissue injury, and other related diseases. In addition, the company provides bacillus cereus live bacteria capsules, bacillus cereus live bacteria tablets are therapeutic live bacteria microecological preparations to treat enteritis, diarrhea, infantile diarrhea, and intestinal dysfunction. The company was founded in 1990 and is headquartered in Tonghua, China.

Similar Companies

Industry: Drug Manufacturers - General (China)
Name
Market Cap diff.
PE
$53.99B
364.89B CNY
1K%
44.9
603259
$49.77B
336.36B CNY
1K%
17.2
$28.52B
223.48B HKD
734%
35.7
$18.8B
147.32B HKD
450%
162.3
$16.56B
111.89B CNY
384%
-
9926
$16.01B
125.46B HKD
368%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
22K%
38.1
JNJ
$547.28B
16K%
26.4
ABBV
$360.63B
10K%
97.4
$321.45B
256.25B CHF
9K%
19.9
AZN
$287.52B
215.59B GBP
8K%
27.6
NOVN
$274.59B
218.9B CHF
8K%
20.5
chevron_leftBack